{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Chula Vista",
      "state": "CA",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "94978",
      "recalling_firm": "SoloVital",
      "address_1": "2571 Mast Way",
      "address_2": "#203",
      "postal_code": "91914-4539",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Nationwide within the United States",
      "recall_number": "D-0620-2024",
      "product_description": "Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.",
      "product_quantity": "1,331 bottles",
      "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.",
      "recall_initiation_date": "20240712",
      "center_classification_date": "20240729",
      "report_date": "20240807",
      "code_info": "All lots within Expiry"
    }
  ]
}